For more than two decades, Dr. Fredric S. Brandt has been a pioneer researcher in the field of cosmetic and clinical dermatology. As the leading dermatological research center in the U.S., Dr. Brandt's Dermatology Research Institute continues to be selected to perform FDA-approved pivotal clinical trials for multinational pharmaceutical and medical device companies.
The Dermatology Research Institute located at the Coral Gables office has a complete state-of-the-art research infrastructure solely dedicated to clinical trials. With a dedicated staff of research professionals under the direction of Alex Cazzaniga BS MBA, Director of Clinical Research, Carolina Padron, Marcella Zavala, Clinical Research Coordinators and Nina Ocon and Jaymie Alvarez, Clinical Research Assistants, Dr. Brandt performs clinical research on FDA-approved protocols, cosmetic ingredients and treatments as well as he develops his own research protocols to evaluate the efficacy of new therapies. Dr. Brandt performs dozens of FDA approved clinical trials annually.
The Institute was instrumental in the FDA approval of Botox Cosmetic, Dysport, Restylane, Perlane, Evolence, Sculptra and several other cosmetic products. The Institute is currently testing the latest generation of muscle relaxant toxins, dermal fillers, and lasers with more than 200 patients enrolled in studies.
The research team's investigational pursuits keep Dr. Brandt at the forefront of medical and technological advances and have allowed him to contribute immensely to his professional field. Dr. Brandt is a frequent lecturer at professional meetings and constantly publishes scientific papers at peer-reviewed journals.
